UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors

Cancer cell international, 2019-08, Vol.19 (1), p.216-216, Article 216

2019

Volltextzugriff (PDF)

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

Molecular medicine (Cambridge, Mass.), 2021-10, Vol.27 (1), p.138-138, Article 138

2021

Volltextzugriff (PDF)

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

Journal of biomedical science, 2024-01, Vol.31 (1), p.17-17, Article 17

2024

Volltextzugriff (PDF)

MET fusions are targetable genomic variants in the treatment of advanced malignancies

Cell communication and signaling, 2024-01, Vol.22 (1), p.20-20, Article 20

2024

Volltextzugriff (PDF)

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer

Molecular medicine (Cambridge, Mass.), 2020-08, Vol.26 (1), p.78-78, Article 78

2020

Volltextzugriff (PDF)

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer

Journal of translational medicine, 2023-02, Vol.21 (1), p.150-150, Article 150

2023

Volltextzugriff (PDF)

Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis

Cellular oncology (Dordrecht), 2021-10, Vol.44 (5), p.1019-1034

2021

Volltextzugriff (PDF)

Advancement in research and therapy of NF1 mutant malignant tumors

Cancer cell international, 2020-10, Vol.20 (1), p.1-492, Article 492

2020

Volltextzugriff (PDF)

Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC

Molecular medicine (Cambridge, Mass.), 2020-07, Vol.26 (1), p.66-66, Article 66

2020

Volltextzugriff (PDF)

ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production

Cell communication and signaling, 2022-10, Vol.20 (1), p.1-156, Article 156

2022

Volltextzugriff (PDF)

ALK rearrangements as mechanisms of acquired resistance to osimertinib in EGFR mutant non‐small cell lung cancer

Thoracic cancer, 2021-03, Vol.12 (6), p.962-969

2021

Volltextzugriff (PDF)

ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma

Translational oncology, 2023-07, Vol.33, p.101685-101685, Article 101685

2023

Volltextzugriff (PDF)

The role of CD28 in the prognosis of young lung adenocarcinoma patients

BMC cancer, 2020-09, Vol.20 (1), p.910-11, Article 910

2020

Volltextzugriff (PDF)

Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing

Frontiers in oncology, 2020-10, Vol.10

2020

Volltextzugriff (PDF)

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency

Cell communication and signaling, 2023-03, Vol.21 (1), p.48-48, Article 48

2023

Volltextzugriff (PDF)

PD‐L1 blockade by immune checkpoint inhibitors impairs sensitivity to osimertinib in EGFR‐mutant non‐small cell lung cancer cells

Cancer innovation (Print), 2022-12, Vol.1 (4), p.348-349

2022

Volltextzugriff (PDF)

CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis

Journal of experimental & clinical cancer research, 2024-07, Vol.43 (1), p.1-15, Article 202

2024

Volltextzugriff (PDF)

Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient

Thoracic cancer, 2020-09, Vol.11 (9), p.2736-2739

2020

Volltextzugriff (PDF)

Role of YES1 signaling in tumor therapy resistance

Cancer innovation (Print), 2023-06, Vol.2 (3), p.210-218

2023

Volltextzugriff (PDF)

Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study

Discover. Oncology, 2024-06, Vol.15 (1), p.213-13

2024

Volltextzugriff (PDF)

Requirement for math5 in the development of retinal ganglion cells

Genes & development, 2001-01, Vol.15 (1), p.24-29

2001

Volltextzugriff (PDF)

Drag derived altitude aided navigation method

Chinese journal of aeronautics, 2017-10, Vol.30 (5), p.1750-1764

2017

Volltextzugriff (PDF)

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma

Cancer biology & therapy, 2020-12, Vol.21 (12), p.1097-1104

2020

Volltextzugriff (PDF)

Evaluated Lymph Node Number in Population-Based Analyses: Significant Prognostic Factor, but Assess With Caution

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.e77-e78

2020

Volltextzugriff (PDF)

Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients

Pathology, research and practice, 2022-10, Vol.238, p.154074-154074, Article 154074

2022

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

MET fusions are targetable genomic variants in the treatment of advanced malignancies

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer

Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis

Advancement in research and therapy of NF1 mutant malignant tumors

Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC

ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production

ALK rearrangements as mechanisms of acquired resistance to osimertinib in EGFR mutant non‐small cell lung cancer

ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma

The role of CD28 in the prognosis of young lung adenocarcinoma patients

Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing

Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency

PD‐L1 blockade by immune checkpoint inhibitors impairs sensitivity to osimertinib in EGFR‐mutant non‐small cell lung cancer cells

CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis

Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient

Role of YES1 signaling in tumor therapy resistance

Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study

Requirement for math5 in the development of retinal ganglion cells

Drag derived altitude aided navigation method

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma

Evaluated Lymph Node Number in Population-Based Analyses: Significant Prognostic Factor, but Assess With Caution

Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients

Suchergebnisse filtern